Actinium Pharmaceuticals (7AY1.F) Q3 2024 Earnings

5AugConfirmed
Q2 2024
Q3 2024
-0.37
-0.34
-0.32
-0.29

Details

Expected EPS
-0.369684
Actual EPS
-0.310352
Surprise EPS
0.06
Surprise Percent
+16.05%

Description

Actinium Pharmaceuticals (7AY1.F) has reported earnings of -0.310352 per share for Q3 2024.

0 Comments

Share your thoughts